ISBA:NASDAQIsabella Bank Corporation Analysis
Data as of 2026-04-11 - not real-time
$48.70
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Isabella Bank trades around $48.7, comfortably above its 20‑day ($45.84) and 50‑day ($47.92) simple moving averages, while the 200‑day SMA sits near $41, indicating a long‑term uptrend. The MACD histogram is positive and the signal line is bearish, flagging a bullish momentum swing, and the RSI of 57 suggests the stock is neither overbought nor oversold. Volatility is elevated at roughly 40% over the past 30 days, but beta is exceptionally low at 0.15, meaning price moves are largely insulated from broader market swings. Fundamentals show a trailing P/E of 19 versus an industry average of 17, yet a forward P/E of 12 points to improving earnings visibility. The DCF‑derived fair value of about $47.2 sits just below the current price, implying the market may be pricing in modest optimism. Recent news includes a director’s purchase at $44.03 and a Q4 earnings miss of 13.5% on EPS, offset by a modest 1.8% revenue beat, underscoring mixed short‑term sentiment.
On the dividend side, a 2.3% yield with a payout ratio under 45% appears sustainable, and the bank’s ROE of ~8.5% supports continued cash generation. The balance sheet shows ample cash ($26.0 M) against debt of $142.5 M, though the debt‑to‑equity metric is effectively zero due to equity structure. With a modest upside potential of roughly 10% to the DCF target and a neutral technical trend, the stock is positioned for a cautious hold in the near term while offering upside for patient investors who value dividend income and steady regional banking exposure.
On the dividend side, a 2.3% yield with a payout ratio under 45% appears sustainable, and the bank’s ROE of ~8.5% supports continued cash generation. The balance sheet shows ample cash ($26.0 M) against debt of $142.5 M, though the debt‑to‑equity metric is effectively zero due to equity structure. With a modest upside potential of roughly 10% to the DCF target and a neutral technical trend, the stock is positioned for a cautious hold in the near term while offering upside for patient investors who value dividend income and steady regional banking exposure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD histogram supporting short‑term momentum
- Price above 20‑day and 50‑day SMAs indicating technical strength
- Recent earnings miss dampening immediate upside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward P/E of 12 suggests earnings‑driven valuation discount
- Sustainable dividend yield of 2.3% with low payout ratio
- Low beta and increasing volume improving risk‑adjusted return
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Stable regional banking franchise with modest revenue growth
- Consistent dividend policy supporting income investors
- Regulatory environment and high volatility warrant caution
Key Metrics & Analysis
Financial Health
Revenue Growth14.30%
Profit Margin23.91%
P/E Ratio19.0
ROE8.56%
ROA0.88%
P/B Ratio1.5
Op. Cash Flow$26.8M
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI57.1
Support$42.97
Resistance$50.88
MA 20$45.84
MA 50$47.92
MA 200$41.00
MACDBullish
VolumeIncreasing
Fear & Greed Index87.09
Valuation
Fair Value$47.16
Target Price$54.00
Upside/Downside10.88%
GradeFair
TypeBlend
Dividend Yield2.30%
Risk Assessment
Beta0.20
Volatility40.18%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.